Low Parathyroid Hormone Versus Secondary Hyperparathyroidism and Survival in Patients Undergoing Hemodialysis: A Propensity-Matched Analysis

Low serum parathyroid hormone (PTH) and secondary hyperparathyroidism (SHPT) are very common in patients undergoing hemodialysis. However, it remains unclear which of these has a lower mortality. In this study, we compared outcomes between hemodialysis patients with low PTH and those with SHPT. This...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Frontiers in endocrinology (Lausanne) 2022-05, Vol.13, p.869330-869330
Hauptverfasser:	Guo, Wang, Zhang, Huixian, Zhang, Yamei, Huang, Hongdong, Liu, Wenhu, Diao, Zongli
Format:	Artikel
Sprache:	eng
Schlagworte:	all-cause death cardio-cerebrovascular death Cohort Studies Endocrinology hemodialysis Humans Hyperparathyroidism, Secondary - epidemiology Hyperparathyroidism, Secondary - etiology low parathyroid hormone Parathyroid Hormone Renal Dialysis - adverse effects Retrospective Studies secondary hyperparathyroidism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Low serum parathyroid hormone (PTH) and secondary hyperparathyroidism (SHPT) are very common in patients undergoing hemodialysis. However, it remains unclear which of these has a lower mortality. In this study, we compared outcomes between hemodialysis patients with low PTH and those with SHPT. This was a multi-center, retrospective, matched cohort study. Median intact PTH (iPTH) was used as the cutoff for allocating participants to low PTH (iPTH
ISSN:	1664-2392 1664-2392
DOI:	10.3389/fendo.2022.869330